Baillie Gifford - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,966
-9.2%
5380.0%0.00%
Q4 2022$6,569
+9.5%
5380.0%0.00%
Q3 2022$6,0000.0%5380.0%0.00%
Q2 2022$6,000
+20.0%
5380.0%0.00%
Q1 2022$5,000
-16.7%
5380.0%0.00%
Q4 2021$6,000
+20.0%
5380.0%0.00%
Q3 2021$5,0000.0%5380.0%0.00%
Q2 2021$5,0000.0%5380.0%0.00%
Q1 2021$5,000
-58.3%
538
+0.6%
0.00%
Q4 2020$12,0005350.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders